Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease and is the most common type of dementia. Although a considerably large amount of money has been invested in drug development for AD, no disease modifying treatment has been detected so far. In our previous work, we developed a compu...

Full description

Bibliographic Details
Main Authors: Kyriaki Savva, Margarita Zachariou, Demos Kynigopoulos, Eleni Fella, Maria-Ioanna Vitali, Xeni Kosofidou, Michail Spyrou, Irene Sargiannidou, Elena Panayiotou, Nikolas Dietis, George M. Spyrou
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Life
Subjects:
Alzheimer’s disease
in vitro testing
in vivo testing
in silico drug repurposing
Online Access:https://www.mdpi.com/2075-1729/13/5/1095

Internet

https://www.mdpi.com/2075-1729/13/5/1095

Similar Items